- ISIN
- US74276R1023
- CUSIP
- 74276R102
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Apr 28, 2021
Highlights
- Market Cap
- $3.07B
- Enterprise Value
- -$405.31B
- EPS (TTM)
- $23.78
- PE Ratio
- 0.99
- PEG Ratio
- 0.01
- Total Revenue (TTM)
- $2.25B
- Gross Profit (TTM)
- $158.32M
- EBITDA (TTM)
- $53.65M
- Year Range
- $18.77 - $26.51
- Target Price
- $31.67
- ROA (TTM)
- 0.22%
- ROE (TTM)
- 0.41%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PRVA Performance Chart
Privia Health Group, Inc. (PRVA) is down 0.9% since the beginning of the year. At $23 per share, PRVA is trading 11.4% below its 52-week high of $27. Investors who bought $1,000 worth of PRVA shares 5 years ago would now be looking at an investment worth $501.
Loading charts...
Returns By Period
Privia Health Group, Inc. (PRVA) has returned -0.93% so far this year and 7.51% over the past 12 months.
Privia Health Group, Inc.
- 1D
- -0.76%
- 1M
- 3.07%
- YTD
- -0.93%
- 6M
- -2.21%
- 1Y
- 7.51%
- 3Y*
- -1.20%
- 5Y*
- -12.90%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PRVA Monthly Returns History
Based on dividend-adjusted daily data since Apr 28, 2021, PRVA's average daily return is +0.06%, while the average monthly return is +1.08%. At this rate, an investment would double in approximately 5.4 years.
Historically, 49% of months were positive and 51% were negative. The best month was Apr 2021 with a return of +57.9%, while the worst month was Nov 2022 at -28.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.
On a daily basis, PRVA closed higher 48% of trading days. The best single day was Apr 29, 2021 with a return of +51.1%, while the worst single day was May 6, 2021 at -13.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.07% | 2.28% | -13.39% | 20.81% | -13.44% | 9.21% | -0.93% | ||||||
| 2025 | 16.88% | 9.28% | -10.09% | 4.59% | -3.07% | 1.05% | -15.13% | 18.03% | 8.07% | -2.41% | 0.29% | -2.71% | 21.28% |
| 2024 | -12.46% | 10.71% | -12.23% | -6.07% | -5.60% | 0.06% | 19.33% | -2.89% | -9.58% | 0.82% | 16.99% | -8.99% | -15.11% |
| 2023 | 19.07% | 3.29% | -1.15% | 0.07% | -9.70% | 4.65% | 6.93% | -5.98% | -12.38% | -8.61% | -1.71% | 11.47% | 1.41% |
| 2022 | -17.74% | 20.96% | 3.85% | -17.73% | 8.96% | 21.54% | 26.30% | 8.18% | -14.40% | -1.70% | -28.52% | -5.10% | -12.21% |
| 2021 | 57.91% | -9.88% | 35.56% | -6.47% | -28.17% | -20.97% | 9.08% | -10.12% | 11.99% | 12.48% |
Benchmark Metrics
Privia Health Group, Inc. has an annualized alpha of 1.38%, beta of 1.03, and R2 of 0.10 versus S&P 500 Index. Calculated based on daily prices since April 28, 2021.
- This stock participated in 57.06% of S&P 500 Index downside but only 27.76% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.10 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 1.38%
- Beta
- 1.03
- R²
- 0.10
- Upside Capture
- 27.76%
- Downside Capture
- 57.06%
Return for Risk
Risk / Return Rank
PRVA ranks 48 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Privia Health Group, Inc. (PRVA) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRVA | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.80 | ||
| Sortino ratioReturn per unit of downside risk | -2.16 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.37 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | 0.31 | 2.78 | -2.47 |
| Martin ratioReturn relative to average drawdown | 0.65 | 12.44 | -11.79 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Privia Health Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Privia Health Group, Inc. was 67.33%, occurring on May 20, 2024. The portfolio has not yet recovered.
The current Privia Health Group, Inc. drawdown is 52.30%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -67.33%May 2024 | 2y 10mo | — | 4y 12moJun 2021 - now |
2021 bear market2021 | -23.34%May 2021 | 8d | 26d | 1mo 4dMay 2021 - Jun 2021 |
2021 pullback2021 | -4.25%Jun 2021 | 0s | 4d | 4dJun 2021 - Jun 2021 |
2021 pullback2021 | -3.85%May 2021 | 1d | 1d | 2dMay 2021 - May 2021 |
2021 pullback2021 | -2.02%Jun 2021 | 0s | 1d | 1dJun 2021 - Jun 2021 |
Drawdown Indicators
| PRVA | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.33% | -56.78% | -10.55% |
Max Drawdown (1Y)Largest decline over 1 year | -24.17% | -9.10% | -15.07% |
Max Drawdown (3Y)Largest decline over 3 years | -42.37% | -18.90% | -23.47% |
Max Drawdown (5Y)Largest decline over 5 years | -67.33% | -25.43% | -41.90% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -52.30% | -1.80% | -50.50% |
Average DrawdownAverage peak-to-trough decline | -48.76% | -10.71% | -38.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.56% | 2.03% | +9.53% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Privia Health Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Privia Health Group, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PRVA, comparing it with other companies in the Health Information Services industry. Currently, PRVA has a P/E ratio of 1.0. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PRVA compared to other companies in the Health Information Services industry. PRVA currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PRVA relative to other companies in the Health Information Services industry. Currently, PRVA has a P/S ratio of 1.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PRVA in comparison with other companies in the Health Information Services industry. Currently, PRVA has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PRVA
Add Privia Health Group, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PRVA